Cleared Traditional

K061932 - BERNOULLI MANAGEMENT SYSTEM (MS) SOFTWARE

K061932 is an FDA 510(k) clearance for BERNOULLI MANAGEMENT SYSTEM (MS) SOFTWARE, manufactured by Cardiopulmonary Corp.. The device is a Class 2 Cardiovascular device with product code MSX cleared through the Traditional 510(k) pathway after a 69-day FDA review.

K061932 · Cardiopulmonary Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
69d
Days
Class 2
Risk

K061932 is an FDA 510(k) clearance for the BERNOULLI MANAGEMENT SYSTEM (MS) SOFTWARE. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Cardiopulmonary Corp. (Milford, US). The FDA issued a Cleared decision on September 14, 2006 after a review of 69 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cardiopulmonary Corp. devices

FDA 510(k) Submission Details - K061932

510(k) Number K061932 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2006
Decision Date September 14, 2006
Days to Decision 69 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 125d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MSX Device Classification - Class 2, Special Controls

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 75
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K061932.
DATEX-OHMEDA S/5 DEVICE INTERFACING SOLUTION, N-DISXXXX..01 WITH N-DISVENT..02
K070421 · Ge Healthcare · Mar 2007
PMP4 APPLICATION
K061428 · Card Guard Scientific Survival , Ltd. · Oct 2006
SPACELABS MEDICAL CLINICAL EVENT INTERFACE, MODEL 91847
K062278 · Spacelabs Medical, Inc. · Sep 2006
WEB VIEWER, POCKET VIEWER AND CELLULAR VIEWER WITH L- WEB05 SOFTWARE
K061994 · Ge Healthcare · Aug 2006
MODIFICATION TO INFINITY EXPLORER
K060254 · Draeger Medical Systems, Inc. · Apr 2006
DATEX-OHMEDA S/5 WEB VIEWER, DATEX-OHMEDA S/5 POCKET VIEWER AND DATEX-OHMEDA S/5 CELLULAR VIEWER WITH L-WEB04 SOFTWARE
K052975 · Ge Healthcare · Jan 2006